Results from a phase I/II single-arm trial suggest that blinatumomab may have an antileukemic effect in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL).
ALL is a progressive...
Results from a phase I/II single-arm trial suggest that blinatumomab may have an antileukemic effect in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL).
ALL is a progressive...
...